Evidence map›Paper›PMID 33293647›Full record

ArticleCell death and differentiation2021

Antiapoptotic Bcl-2 family proteins BCL-xL and MCL-1 integrate neural progenitor survival and proliferation during postnatal cerebellar neurogenesis.

Katherine A Veleta, Abigail H Cleveland, Benjamin R Babcock, You-Wen He, Duhyeong Hwang, Marina Sokolsky-Papkov, Timothy R Gershon

Open access · bronzeAbstract read
In one paragraph

Article in Cell death and differentiation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. The Role of Mcl-1 in Embryonic Neural Precursor Cell Apoptosis.Frontiers in cell and developmental biology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Katherine A Veleta *UNC Neuroscience Center, University of North Carolina, Chapel Hill, NC, 27599, USA.
Abigail H Cleveland *UNC Cancer Cell Biology Training Program, University of North Carolina, Chapel Hill, NC, 27599, USA.
Benjamin R BabcockDepartment of Neurology, UNC School of Medicine, University of North Carolina, Chapel Hill, NC, 27599, USA.
You-Wen HeDepartment of Immunology, Duke University, Durham, NC, 27708, USA.ORCID http://orcid.org/0000-0002-8983-2684
Duhyeong HwangCenter for Nanotechnology in Drug Delivery and Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
Marina Sokolsky-PapkovCenter for Nanotechnology in Drug Delivery and Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
Timothy R GershonUNC Neuroscience Center, University of North Carolina, Chapel Hill, NC, 27599, USA. gershont@neurology.med.unc.edu.ORCID http://orcid.org/0000-0001-7034-6400
University of North Carolina at Chapel Hill · USDuke University · US

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Melissa A. Troester · 2001 to 2026
$36.3M
Targeting the MEKK2-ERK5 Signaling Node in Triple Negative Breast CancerU54CA156733 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LINNAN, LAURA A · 2010 to 2020
$9.7M
CANCER CELL BIOLOGY TRAINING PROGRAMT32CA071341 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CHANNING J. DER, Yuliya Pylayeva-Gupta · 1996 to 2026
$5.0M
Bcl-xL-regulated apoptosis in cerebellar development and medulloblastoma treatmentR01NS102627 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI GERSHON, TIMOTHY · 2018 to 2022
$1.8M
Defining the crucial role of MAGOH in cerebellar development and the potential for targeting the EJC in medulloblastoma treatmentR01NS106227 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI GERSHON, TIMOTHY · 2018 to 2023
$1.7M
Glycolytic regulation of cerebellar development and medulloblastoma tumorigenesisR01NS088219 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI GERSHON, TIMOTHY · 2015 to 2019
$1.6M
Cooperation of BCL-xL and SHH in regulating cell survival during cerebellar neurogenesis and in medulloblastomaF31NS101883 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI VELETA, KATHERINE · 2017 to 2019
$63k
NCI NIH HHS P30 CA016086NCI NIH HHS T32 CA071341NCI NIH HHS U54 CA156733NIEHS NIH HHS P30 ES010126NINDS NIH HHS F31 NS101883NINDS NIH HHS R01 NS088219NINDS NIH HHS R01 NS102627NINDS NIH HHS R01 NS106227
6 · The paper itself

Abstract

The tendency of brain cells to undergo apoptosis in response to exogenous events varies across neural development, with apoptotic threshold dependent on proliferation state. Proliferative neural progenitors show a low threshold for apoptosis, while terminally differentiated neurons are relatively refractory. To define the mechanisms linking proliferation and apoptotic threshold, we examined the effect of conditionally deleting Bcl2l1, the gene that codes the antiapoptotic protein BCL-xL, in cerebellar granule neuron progenitors (CGNPs), and of co-deleting Bcl2l1 homologs, antiapoptotic Mcl-1, or pro-apoptotic Bax. We found that cerebella in conditional Bcl2l1-deleted (Bcl-xL

Indexed as

AnimalsCell ProliferationCerebellar NeoplasmsHumansMiceMyeloid Cell Leukemia Sequence 1 ProteinNeurogenesisProto-Oncogene Proteins c-bcl-2Signal TransductionMcl1 protein, mouseMyeloid Cell Leukemia Sequence 1 ProteinProto-Oncogene Proteins c-bcl-2

Identifiers

PMID33293647
PMCPMC8166857
OpenAlexW3111115731

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.